News Manufacturing issues block FDA nod for Scholar Rock SMA drug Unresolved issues at a manufacturing plant operated by Novo Nordisk have led to a complete response letter for Scholar Rock's SMA drug apitegromab.
News As Trump visits UK, GSK pledges $30bn in US investment GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.
News Gilead, Amgen kick off facility investments in US This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.
News Roche breaks ground on US manufacturing facility Roche's Genentech unit has started work on a $700m manufacturing facility in North Carolina, part of a promised $50bn US investment programme.
News J&J earmarks $2bn for facility in North Carolina Johnson & Johnson has filled in some of the detail in its $55 billion investment in US facilities announced earlier this year.
News Trump orders stockpiling of essential medicine ingredients Trump has ordered the creation of a six-month stockpile of ingredients to make essential medicines, in another part of his push to reshore production.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.